In metastatic melanoma, miR-222's promoter binds directly to ETS-1, where phosphorylation status influences its expression; conversely, non-phosphorylated ETS-1 in early melanoma suppresses miR-222 transcription [77]. Here, ETS1 is linked to melanoma.